to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Clinical trial NCT07265466 · RECRUITING
Trial details
- NCT number
- NCT07265466
- Sponsor
- Onconic Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-17
- Primary completion
- 2026-03-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.